Results 1 to 10 of about 2,173 (102)

Giant Brunner’s gland adenoma of the duodenum complicated with bleeding: a case report [PDF]

open access: yes, 2022
Brunner’s gland adenoma(BGA) of the duodenum is an extremely rare benign tumor in clinical practice. In this article, the diagnosis and treatment of one case of BGA of the duodenum were reported.
Xu Qi, Wang Yan, Tang Jing, Gao Fei, Zhang Jiewei, Zhuang Guifeng
core   +1 more source

Autoimmune polyendocrine syndrome type 2 complicated with hyperthyroidism crisis and diabetic acute complications: a case report and literature review [PDF]

open access: yes, 2023
Objective To enhance clinicians’ diagnosis and treatment capability for autoimmune polyendocrine syndrome type 2 (APS-2),and reduce missed diagnosis and misdiagnosis.
Jian Li, Wu Qinan, Zhao Qiquan, LYU Xinlu
core   +1 more source

Autoimmune Neutropenia in Children:Clinical Characteristics [PDF]

open access: yes, 2022
BackgroundAutoimmune neutropenia (AIN) is a common chronic neutropenia in children, but it in children has been rarely reported.ObjectiveTo analyse clinical characteristics, diagnosis, treatment, and follow-up of children with AIN, aiming at providing ...
SUN Qing, XIE Yao, WU Penghui, LI Shuo, ZHAO Weihong
core   +1 more source

Clinical study on high-risk factors for contralateral lymph node metastasis in unilateral papillary thyroid carcinoma [PDF]

open access: yes, 2023
Background and purpose: The occurrence of lymph node metastasis in papillary thyroid cancer (PTC) can have adverse effects on the prognosis of patients. This study aimed to investigate risk factors related to the occurrence of contralateral central lymph
YUAN Xinyue, YAO Yao, CHENG Shuai, ZHENG Xin, ZHANG Yuan
core   +1 more source

桥本甲状腺炎细胞病理分级与甲状腺功能和Hb、RBC、WBC及PLT的相关性研究

open access: yesZhongguo shiyan zhenduanxue, 2021
目的通过细针穿刺细胞病理学对桥本甲状腺炎(Hashimoto’s thyroiditis,HT)进行分级,并进一步探讨甲状腺功能、主要血常规参数与细胞学分级之间的相关性。方法对39名经细胞病理学检查确诊为HT的患者的病理涂片进行回顾性分析,并根据细胞学分级标准进行分级。患者均完成游离甲状腺素(FT4)、游离三碘甲状腺氨酸(FT3)、促甲状腺激素(TSH)、甲状腺球蛋白抗体(TGAb)、甲状腺过氧化物酶抗体(TPOAb)及血常规等检查。结果大多数患者为桥本甲状腺炎1级(56.4%),其次是2级(28.2%)
王春, 石娜, 王崇高, 王康
doaj  

A case-control study on the association of Hashimoto’s thyroiditis and anti-thyroid antibodies with oral lichen planus [PDF]

open access: yes
Objective This study aims to explore the association between oral lichen planus (OLP) and Hashimoto’s thyroiditis (HT) and its anti-thyroid antibodies to provide clinical evidence for thyroid disease screening in patients with OLP. Methods This study was
LIU Yuan, CHEN Yan, CONG Zhaoxia, LI Yiming, XUE Rui, ZHAO Jin
core   +1 more source

Correlation analysis of bile acid spectrum and thyroid function in patients with autoimmune liver disease [PDF]

open access: yes
"Objective To explore the correlation between bile acid metabolic components and thyroid function indicators in patients with autoimmune liver disease(AILD).
SONG Keyu,QIAO Runjie,WANG Wenjing,ZHANG Qin,TAN Guolei
core   +2 more sources

血清Tg、TSH检测对甲状腺癌术前N分期的诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2023
目的 探讨血清甲状腺球蛋白(Tg)、促甲状腺激素(TSH)对甲状腺癌术前N分期的诊断价值。方法 回顾性分析106例经手术病理证实的甲状腺癌患者临床资料,根据术后病理N分期,将患者分为pN1、pN1a和pN1b期;比较不同分期Tg、TSH等血清标志物水平,用Logistic回归模型分析N分期的影响因素,并构建Tg、TSH诊断甲状腺癌术前N分期的受试者工作特征(ROC)曲线。结果 相比pN0期组,pN1期组血清Tg、TSH水平均显著增高(P0.05)。Logistic回归分析显示,血清Tg ...
岳鑫, 罗征, 朱晓月
doaj  

Meta-analysis of Chaihu Shugan Powder in the treatment of Hashimoto’s thyroiditis [PDF]

open access: yes
Objective To evaluate the efficacy and safety of Chaihu Shugan Powder in the treatment of Hashimoto’s thyroiditis. Methods Randomized controlled trials of Chaihu Shugan Powder in the treatment of Hashimoto’s thyroiditis were searched from China Knowledge
DENG Hongxiao, LIU Yansong, WANG Yaya, SI Xinying, DING Zhiguo
core   +1 more source

Correlation between blood lipids and risk of thyroid nodules in euthyroid women [PDF]

open access: yes
ObjectiveTo explore the correlation and dose-response relationship between blood lipid parameters and the risk of thyroid nodules (TNs) in euthyroid women, providing references for disease prevention.
Fangfang ZENG   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy